{
    "case_number": "CAC-UDRP-100938",
    "time_of_filling": "2015-03-03 13:09:59",
    "domain_names": [
        "boehringer--ingelheim.com"
    ],
    "case_administrator": "Lada Válková (Case admin)",
    "complainant": [
        "BOEHRINGER Ingelheim Pharma GmbH & Co. KG"
    ],
    "complainant_representative": "Nameshield (Anne Morin)",
    "respondent": [
        "VistaPrint Technologies Ltd"
    ],
    "respondent_representative": null,
    "factual_background": "FACTS ASSERTED BY THE COMPLAINANT AND NOT CONTESTED BY THE RESPONDENT:\r\n\r\nThe Complainant maintains that it is one of the world's twenty leading research-driven pharmaceutical companies in the human and veterinary heath sectors, with a history spanning over 125 years. It states that it has 142 affiliated companies world-wide with some 47,000 employees and recent turnover exceeding €14 billion. The Complainant has shown that it owns several trademarks trademarks in several countries consisting in the wording Boehringer Ingelheim and that it has constructed a significant portfolio of domain names around this wording, including in its hyphenated variants.\r\n\r\nThe Complainant has also shown that it sent a cease-and-desist letter to the Respondent, to which no response was received. And it has provided extensive evidence of WIPO UDRP proceedings which have both upheld its own claims against cybersquatters and held against the Respondent on the basis of complaints brought by other right-holders. The Complainant was thereby able to show a pattern of bad faith registrations on behalf of the Respondent.",
    "other_legal_proceedings": "No other proceedings have been notified to the Panel.",
    "no_response_filed": "NO ADMINISTRATIVELY COMPLIANT RESPONSE HAS BEEN FILED.",
    "rights": "The Complainant has, to the satisfaction of the Panel, shown the Domain Name is identical or confusingly similar to a trademark or service mark in which the complainant has rights (within the meaning of paragraph 4(a)(i)of the Policy).",
    "no_rights_or_legitimate_interests": "The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the Domain Name (within the meaning of paragraph 4(a)(ii)of the Policy).",
    "bad_faith": "The Complainant has, to the satisfaction of the Panel, shown the Domain Name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii)of the Policy).",
    "procedural_factors": "The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.",
    "decision": "Accepted",
    "panelists": [
        "Kevin J. Madders"
    ],
    "date_of_panel_decision": "2015-04-25 00:00:00",
    "informal_english_translation": "Numerous trademarks under several Nice Classification categories are registered in favour of the Complainant in a range of jurisdictions. These marks include the hyphenated form of Boehringer Ingelheim in Classes 01, 02, 03, 04, 05, 06, 16, 17, 19, 29, 30 and 32. The Complainant has furthermore offered extensive proof of longstanding reputation associated with its brand and of being the holder of several domain name registrations, including boehringer-ingelheim.com and other hyphenated forms of generic TLDs corresponding to its brand. \r\n\r\nThe rights  identified relate in particular to pharmaceutical products which have been marketed on the basis of the notoriety the Boehringer Ingelheim brand has won in the human and veterinary services pharmaceuticals sectors worldwide.",
    "decision_domains": {
        "BOEHRINGER--INGELHEIM.COM": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}